Our top pick for
Avantor, Inc is a specialty chemicals business based in the US. Avantor shares (AVTR) are listed on the NYSE and all prices are listed in US Dollars. Avantor employs 12,000 staff and has a trailing 12-month revenue of around USD$6 billion.
Since the stock market crash in March caused by coronavirus, Avantor's share price has had significant positive movement.
Its last market close was USD$27.07, which is 34.10% up on its pre-crash value of USD$17.84 and 306.76% up on the lowest point reached during the March crash when the shares fell as low as USD$6.655.
If you had bought USD$1,000 worth of Avantor shares at the start of February 2020, those shares would have been worth USD$547.28 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,455.28.
|Latest market close||USD$27.07|
|52-week range||USD$8.3 - USD$24.97|
|50-day moving average||USD$22.7265|
|200-day moving average||USD$19.0667|
|Wall St. target price||USD$24.61|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.232|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-17)||-1.92%|
|1 month (2020-10-23)||8.71%|
|3 months (2020-08-24)||26.38%|
|6 months (2020-05-22)||51.82%|
|1 year (2019-11-22)||57.75%|
|2 years (2018-11-20)||N/A|
|3 years (2017-11-20)||N/A|
|5 years (2015-11-20)||N/A|
Valuing Avantor stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avantor's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avantor's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Avantor shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Avantor's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$1 billion.
The EBITDA is a measure of a Avantor's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$6 billion|
|Operating margin TTM||10.81%|
|Gross profit TTM||USD$1.9 billion|
|Return on assets TTM||4.1%|
|Return on equity TTM||8.07%|
|Market capitalisation||USD$14.1 billion|
TTM: trailing 12 months
There are currently 13.6 million Avantor shares held short by investors – that's known as Avantor's "short interest". This figure is 8.1% down from 14.8 million last month.
There are a few different ways that this level of interest in shorting Avantor shares can be evaluated.
Avantor's "short interest ratio" (SIR) is the quantity of Avantor shares currently shorted divided by the average quantity of Avantor shares traded daily (recently around 5.4 million). Avantor's SIR currently stands at 2.51. In other words for every 100,000 Avantor shares traded daily on the market, roughly 2510 shares are currently held short.
However Avantor's short interest can also be evaluated against the total number of Avantor shares, or, against the total number of tradable Avantor shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avantor's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Avantor shares in existence, roughly 20 shares are currently held short) or 0.0452% of the tradable shares (for every 100,000 tradable Avantor shares, roughly 45 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Avantor.
Find out more about how you can short Avantor stock.
We're not expecting Avantor to pay a dividend over the next 12 months.
Avantor, Inc. provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Steps to owning and managing AKR, with 24-hour and historical pricing before you buy.
Steps to owning and managing WPP, with 24-hour and historical pricing before you buy.
Steps to owning and managing WY, with 24-hour and historical pricing before you buy.
Steps to owning and managing WEYS, with 24-hour and historical pricing before you buy.
Steps to owning and managing WAB, with 24-hour and historical pricing before you buy.
Steps to owning and managing VSH, with 24-hour and historical pricing before you buy.
Steps to owning and managing VLGEA, with 24-hour and historical pricing before you buy.
Steps to owning and managing VMD, with 24-hour and historical pricing before you buy.
Steps to owning and managing UONE, with 24-hour and historical pricing before you buy.
Steps to owning and managing UMRX, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.